Terms: = Sarcomas AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
3 results:
1. Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y; Tazawa H; Demiya K; Kure M; Kondo H; Komatsubara T; Sugiu K; Hasei J; Yoshida A; Kunisada T; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Immunol Immunother; 2021 May; 70(5):1405-1417. PubMed ID: 33151368
[TBL] [Abstract] [Full Text] [Related]
2. FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.
Das N; Thakral D; Singh G; Malhotra A; Phulware RH; Gogia A; Gupta R
Indian J Pathol Microbiol; 2019; 62(4):614-617. PubMed ID: 31611454
[TBL] [Abstract] [Full Text] [Related]
3. Efficient detection of the V600E mutation of the BRAF gene in papillary thyroid carcinoma using multiplex allele-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography.
Gong RX; Gong YP; Yang J; Wei T; Li-Ling J; Zhu JQ
Genet Mol Res; 2013 Oct; 12(4):4990-7. PubMed ID: 24301760
[TBL] [Abstract] [Full Text] [Related]